JP2025514872A5 - - Google Patents
Info
- Publication number
- JP2025514872A5 JP2025514872A5 JP2024556456A JP2024556456A JP2025514872A5 JP 2025514872 A5 JP2025514872 A5 JP 2025514872A5 JP 2024556456 A JP2024556456 A JP 2024556456A JP 2024556456 A JP2024556456 A JP 2024556456A JP 2025514872 A5 JP2025514872 A5 JP 2025514872A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- recombinant polypeptide
- amino acid
- domain
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22164123.6A EP4249506A1 (en) | 2022-03-24 | 2022-03-24 | Mhc 1b-mediated alpha-synuclein-specific tolerance induction as a novel treatment for parkinson's disease |
| EP22164123.6 | 2022-03-24 | ||
| PCT/EP2023/057682 WO2023180548A1 (en) | 2022-03-24 | 2023-03-24 | Mhc 1b-mediated alpha-synuclein-specific tolerance induction as a novel treatment for parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514872A JP2025514872A (ja) | 2025-05-12 |
| JP2025514872A5 true JP2025514872A5 (https=) | 2026-02-20 |
Family
ID=81384775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556456A Pending JP2025514872A (ja) | 2022-03-24 | 2023-03-24 | パーキンソン病の新規治療法としてのＭＨＣ １ｂを介したα－シヌクレイン特異的耐性誘導 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250205321A1 (https=) |
| EP (2) | EP4249506A1 (https=) |
| JP (1) | JP2025514872A (https=) |
| KR (1) | KR20240162549A (https=) |
| CN (1) | CN119317639A (https=) |
| AU (1) | AU2023238805A1 (https=) |
| CA (1) | CA3250917A1 (https=) |
| CL (1) | CL2024002724A1 (https=) |
| CO (1) | CO2024012329A2 (https=) |
| IL (1) | IL314741A (https=) |
| MX (1) | MX2024011665A (https=) |
| WO (1) | WO2023180548A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024344683A1 (en) * | 2023-09-22 | 2026-04-02 | Julius-Maximilians-Universität Würzburg, In Vertretung Des Freistaates Bayern | Mhc 1b-mediated alpha-synuclein-specific tolerance induction as a novel treatment for parkinson's disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3630809A1 (en) | 2017-05-23 | 2020-04-08 | Bruttel, Valentin | Combinations of mhc class ib molecules and peptides for targeted therapeutic immunomodulation |
-
2022
- 2022-03-24 EP EP22164123.6A patent/EP4249506A1/en not_active Withdrawn
-
2023
- 2023-03-24 JP JP2024556456A patent/JP2025514872A/ja active Pending
- 2023-03-24 US US18/849,009 patent/US20250205321A1/en active Pending
- 2023-03-24 WO PCT/EP2023/057682 patent/WO2023180548A1/en not_active Ceased
- 2023-03-24 KR KR1020247034476A patent/KR20240162549A/ko active Pending
- 2023-03-24 MX MX2024011665A patent/MX2024011665A/es unknown
- 2023-03-24 CA CA3250917A patent/CA3250917A1/en active Pending
- 2023-03-24 EP EP23715474.5A patent/EP4499682A1/en active Pending
- 2023-03-24 IL IL314741A patent/IL314741A/en unknown
- 2023-03-24 AU AU2023238805A patent/AU2023238805A1/en active Pending
- 2023-03-24 CN CN202380029745.8A patent/CN119317639A/zh active Pending
-
2024
- 2024-09-11 CL CL2024002724A patent/CL2024002724A1/es unknown
- 2024-09-11 CO CONC2024/0012329A patent/CO2024012329A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| L Dudek et al. | Epitope discovery and their use in peptide based vaccines | |
| EP1594896B1 (en) | Modified soluble t cell receptor | |
| Mézière et al. | In vivo T helper cell response to retro-inverso peptidomimetics | |
| JP2023524054A5 (https=) | ||
| JP2020521000A5 (https=) | ||
| AU730477B2 (en) | MHC binding peptide oligomers and methods of use | |
| JP2023504172A5 (https=) | ||
| RS63501B1 (sr) | T ćelijski receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02 | |
| RS63371B1 (sr) | T ćelijski receptori | |
| JP2012509071A5 (https=) | ||
| JP2012516140A5 (https=) | ||
| TW200902049A (en) | Fusion protein | |
| CN114174329A (zh) | 肽-mhc复合物 | |
| WO2017089779A1 (en) | Peptides derived from achaete-scute homolog 2 (ascl2), complexes comprising such peptides bound to mhc molecules | |
| Cheloha et al. | Recognition of class II MHC peptide ligands that contain β-amino acids | |
| JP2025514872A5 (https=) | ||
| US11851469B2 (en) | Soluble heterodimeric T cell receptor, and preparation method and use thereof | |
| CN100467063C (zh) | 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用 | |
| JP2025510786A5 (https=) | ||
| EP4499662A1 (en) | Combination of epitopes and use thereof, vaccine construct, method of inducing an immune response, method for the identification of epitopes | |
| CN118891059A (zh) | 嵌合多肽 | |
| CN118946367A (zh) | 嵌合多肽 | |
| JP2025513720A5 (https=) | ||
| CN112512552B (zh) | 自组装肽支架 | |
| EP3380499A1 (en) | Peptides derived from transient receptor potential cation channel subfamily m member 1 (trpm1), complexes comprising such peptides bound to mhc molecules |